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ost diseases are thought to arise from the com-
bined effects of genes and the environment.
While great strides have been made in our under-
standing of human genetics, the contribution of envi-
ronmental exposures to disease remains poorly
understood. This lack of understanding impedes real
progress in identifying genetically susceptible people
whose responses to environmental agents are severe or
unique relative to the general population. If identified,
targeted prevention and treatment strategies might be
applied to these groups, with potentially lifesaving
results. Without more personal exposure information,
however, scientists have a limited ability to identify
pollution-susceptibility genes that elevate disease risk. 
This mismatch between exposure and genetic
research slows the identification of environmental
factors that—if altered or removed—could even
prevent some diseases from occurring in the first place. 
Monitoring Environmental Exposures
NowIt’s Personal“Genes aren’t modifiable,” explains Frederica
Perera, a professor of environmental health
sciences at the Mailman School of Public
Health of Columbia University. “So, these
environmental components in diet, food,
water, and air are the only ones we can act
on for disease prevention.”
Exposure is, at a core level, the instance
of environmental stimuli such as chemi-
cals, infectious agents, diet, and lifestyle
factors interacting with the human body.
But studying human exposures poses diffi-
cult challenges. Scientists studying the
effects of chemical pollutants can’t ethical-
ly dose people, so they often base their
dose–response estimates on animal models.
Further, they base their estimates of human
exposure on indirect measures taken from a
person’s home or work environment, along
with assumptions about individual behav-
iors that influence the risk of coming into
contact with a given pollutant. In a typical
study, epidemiologists might use census
figures, questionnaires, and general envi-
ronmental monitoring data (such as sam-
ples of water from a household tap or soil
in a schoolyard) to estimate how much of a
given chemical an individual has come into
contact with, and for how long. 
But while these studies approximate
population-level exposures, they provide
little information about real exposures to
individual people. And because of this, sci-
entists know little about how specific pol-
lutants—particularly in combination with
each other, with diet, and with physical
activity—affect any individual’s response
to the pollutant. 
With a clear need for progress, exposure
assessment has recently come under the
spotlight. This year, the NIEHS launched
the Exposure Biology Program (EBP), a
four-year effort with two overarching
goals: to improve exposure assessment
technology, and to identify biomarkers for
common pathogenic mechanisms that
reflect the human response to environmen-
tal agents. Such biomarkers could include
changes in metabolites, proteins, or DNA
that reflect the individual’s genetic suscep-
tibility to environmental harm.
“Right now we don’t really understand
how exposure levels translate to human
health risk, so our goal is to fill that gap,”
says EBP coordinator Brenda Weis, a sen-
ior scientific advisor at NIEHS. “We need
to get a better measure of exposure at the
point of human contact, and we need to
integrate those measures with biological
response measures derived from samples
taken directly from exposed people. So,
this is a more ‘medical’ approach to expo-
sure assessment—in the sense that meas-
ures are taken on a personal level—rather
than the broader, ecological approaches
we’ve been using so far.” 
The Genes and Environment
Initiative
The EBP is part of the larger DHHS
Genes and Environment Initiative (GEI),
which was established on 8 February
2006. This initiative links the EBP with a
complementary genome association pro-
gram, led by the National Human Genome
Research Institute (NHGRI), which is
dedicated to finding genetic risk factors
for environmental diseases. 
NIEHS director David Schwartz and
NHGRI director Francis Collins initially
hatched the idea for a joint collaboration
two years ago. At first, the two scientists pro-
posed assembling a vast cohort of 1 million
Americans for a 10-year prospective study of
gene–environment interactions in health.
However, that plan has not yet material-
ized, because of its high anticipated cost—
estimated at up to $3 billion—and also
because experts at both agencies felt that
policies for genetic privacy and other social
issues needed to be further developed before
such a large study could be undertaken.
The GEI was therefore proposed as a
more limited effort encompassing smaller
population studies and fewer diseases.
“Schwartz will head the exposure piece
while Collins will head up the GEI’s
genome association studies,” Weis explains.
“The idea was to unite our mutual expert-
ise—we worked for a long time on the con-
cept, and we wound up with forty million
dollars in annual funding for four years.”
NIH director Elias Zerhouni said of the
GEI upon its launch that “[this initiative]
would not have been possible a year or two
ago.” Recent years have given rise to med-
ical and computational advances that make
detailed studies of gene–environment
interactions increasingly more feasible. The
cost of genotyping, for instance, meaning
the identification of specific genetic vari-
ants at one or more loci in an individual,
has dropped by more than 100-fold, mak-
ing the initiative’s genome association com-
ponent more affordable. Environmental
sensors that monitor individual pollution
exposures, physical activity patterns, and
corresponding physiological responses have
also met with rapid progress, bringing goals
for personalized exposure assessment with-
in reach.
Through the EBP, Weis says, the
NIEHS will develop technologies that pro-
duce more precise measures of exposure,
and with that, better biomarkers of physio-
logical response. The NHGRI, meanwhile,
plans to apply those biomarkers toward
genome association studies in specific ill-
nesses, such as cancer, respiratory ailments,
and heart disease. “We’ll also offer input on
the [biomarkers of] exposure that the scien-
tists select,” says Teri Manolio, a senior advi-
sor at the NHGRI managing GEI-related
activities. “We need to be sure they relate to
genetics as well as environment.” Through
the combined efforts of both institutes, adds
Weis, the GEI will accelerate progress on
gene–environment research and lay the
technical and social foundations for larger
studies in the future. 
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Outside impacts on inside systems. Measuring responses to factors such as sun exposure and
allergies may provide important information about the health impact of environmental stress.A step forward on the NIEHS’s exposure
assessment agenda occurred on 16–17 May
2006, when academic, government, and
industry experts convened in Greensboro,
North Carolina, for the NIH Exposure
Biology Workshop, hosted by the NIEHS
and the NHGRI. At the workshop, experts
deliberated the pitfalls and promises of
exposure assessment, and produced a series
of recommendations for optimizing sensor
technology and biomarker development. 
The meeting was remarkably interdisci-
plinary, participants say. “I’m used to going
to meetings where I know everyone,” says
Martyn Smith, a professor of toxicology at
the University of California, Berkeley, who
was in attendance. “But I didn’t know many
of the people there, and I think that’s a
good thing. There needs to be more inter-
action between the engineers who design
exposure instruments and we in environ-
mental health who apply them in the field.”
New Sensations
Among the tools used to monitor expo-
sures now are laser-based sensors that
assess population exposures to industrial
stack emissions, wearable dosimeters that
measure chemicals and radiation (generally
in occupational settings), accelerometers
that measure physical activity, and biosen-
sors that can detect specific analytes in
the body. 
New technologies to assess personal
exposures are being conceptualized, but
developments are moving slowly. A
research article by Weis and colleagues
published in the July 2005 issue of EHP
outlines current, ongoing efforts. The arti-
cle describes promising applications that
link geographic information system (GIS)
technology with fate and transport models
to derive individual exposure metrics for
pesticides, drinking water contaminants,
and air pollutants. The article further
reports that researchers have used GIS
with Global Positioning System (GPS)
technology to define activity patterns that
could conceivably be linked to environ-
mental data for exposure assessment.
However, sources contacted for the pres-
ent article were unaware of any existing
GIS applications for environmental epi-
demiology research. 
Some of the most exciting sensing
opportunities have come from military
and biomedical research. The military has
produced sensors that detect biological
warfare agents such as anthrax down to the
level of a single spore. Medical researchers,
meanwhile, have developed biosensors
that detect isolated binding events in sin-
gle cells, in addition to variables like heart
rate, respiratory function, and changes in
enzyme levels. “We have a glaring, obvious
opportunity to adapt these tools for envi-
ronmental exposure assessment,” says
David Walt, a professor of chemistry at
Tufts University. “We can use them to
monitor the ambient environment as well
as personal exposure. We now have the
capability to take all those measurements
and link them together.” 
Future sensing opportunities are noth-
ing short of extraordinary. Subjects could be
injected with nanoscale biosensors that light
up when they detect exposure-induced
molecular changes. “After a period of time,
a blood sample could be taken, the biosen-
sors could be fished out, and you’d see pre-
cisely what you’d been exposed to,” Walt
speculates. “The techniques are available
now, but they haven’t been addressed to
environmental exposure.” Some biosensors
outfitted with microtransducers could relay
information about cellular changes with
electronic signals, he adds. “And in those
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It’s a combo deal. Any given person has a highly unique suite of exposures, making individual-level exposure assessment a must for teasing out
how factors such as diet and physical activity influence people’s responses to particular pollutants. 
Environmental Health Perspectives • VOLUME 114 | NUMBER 9 | September 2006  A 531cases you might not even have to take the
blood sample—you could read an integrat-
ed signal of all the particles in an interroga-
tion zone right through the skin.”
William Haskell, a professor at the
Stanford University School of Medicine,
proposes to create a portable device that
measures physical activity, pollution expo-
sure, and other variables simultaneously in
real time. The sensing instruments, he
suggests, could be loaded onto a GPS-
enabled cell phone into which subjects
could record their diet and other pertinent
information using the keypad. 
Haskell is collaborating on the con-
cept with Stephen Intille, a research scien-
tist at the Massachusetts Institute of
Technology who’s been developing wire-
less motion sensors to measure a variety of
human behaviors. Their immediate goal is
to create cell phone–adaptable software
that distinguishes whether someone is
walking, riding a bike, working in the
yard, or doing something else, all accord-
ing to how their physical motions affect
heart rate, and how they accelerate and
decelerate over time. That capability,
along with GPS and sensors that detect
chemicals in the cell phone’s immediate
vicinity, could give scientists unprecedent-
ed access to the locations, activities, diets,
and chemical exposures of individuals in a
given cohort. 
What would scientists do with that
information? “Say you were a pediatrician
in Los Angeles,” Haskell proposes, “and
you wanted to understand what triggers
asthma in kids. With these more advanced
technologies you could plot their activity
patterns against pollution exposure levels.
That would allow you to draw a personal
profile that, upon being transmitted by
the cell phone, could be automatically
downloaded onto a server. We could use
that information to determine the specific
components in air pollution that trigger
asthma in high-risk individuals. We have
the technical capability to do this now; it’s
just a matter of pulling the resources
together for this particular purpose.” 
Future sensors, scientists say, need to be
even faster, cheaper, and more portable
than they are now. Participants at the May
workshop called for more collaboration
with sensor developers, and clear lines of
communication regarding the specific
measurements needed to move exposure
assessment forward. Along these lines,
“high-benefit” opportunities are expected
in lab-on-a-chip platforms (which analyze
pollutants in the field as opposed to in the
laboratory) and multiplexed sensors that
monitor multiple pollutants simultaneously.
Fingering the Biomarkers 
The chief goal, of course, is to link expo-
sure measurements to biomarkers that
reflect a physiological response. John
Groopman, who chairs the Department of
Environmental Health Sciences at the Johns
Hopkins Bloomberg School of Public
Health, argues that scientists should first
seek biomarkers for diseases with known
links to the environment. “And certainly a
number of lung-related effects fulfill that
criteria,” he says. 
Weis agrees, and points out that the
EBP’s first project, an airway disease proj-
ect launched in 2006, will investigate the
impacts of cigarette smoke, ozone, cock-
roach dander, and lipopolysaccharide
(found on the cell walls of Gram-negative
bacteria) on two processes related to respi-
ratory disease: inflammation and oxidative
stress. “It would be really informative to
find a panel of biomarkers that’s specific to
each of these agents,” she says. 
Scientists will begin by searching for
putative biomarkers in animals that can be
further investigated in people going about
their daily business who will be outfitted
with personal exposure monitors. Another
goal is to use exposure agents to find bio-
markers that distinguish different types of
asthma—for instance, using an immune
response triggered by cockroach dander to
distinguish allergenic asthma from nonal-
lergenic asthmatic reactions caused by
other environmental agents. “People with
different types of asthma could be treated
with therapies tailored to their type of asth-
ma,” Weis explains. “But we need to
understand the mechanistic differences
between the various manifestations of the
disease. We want to better understand
those mechanisms so we can improve treat-
ment and prevention options.”
Focusing on inflammation and oxida-
tive stress makes additional sense because
both pathways are also common to other
ailments, including cancer and heart dis-
ease. But scientists studying these pathways
must consider their normal equilibrium,
stresses Martha Monick, a research scientist
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Phoning in the facts. New sensor technologies will make use of cell phones and similar apparatus to continuously monitor individuals as they go about
daily life, recording data on physical activity, environmental exposures, and measures such as heart rate and respiration.Environmental Health Perspectives • VOLUME 114 | NUMBER 9 | September 2006  A 533
at the University of Iowa. Inflammation
and oxidative stress normally protect the
body from pathogens and are only toxic
when overstimulated, she says, and that
natural variability should be considered
during the exposure assessment. Moreover,
she adds, the inflammatory response to
environmental factors can, in some cases,
merely exacerbate preexisting conditions
with nonenvironmental origins. For in-
stance, atherosclerosis, a progressive vascu-
lar disease with an underlying basis in
genetics, can be aggravated by exposure to
cigarette smoke and air pollutants such as
particulate matter. “So it would be helpful
to have biomarkers for exposures that pro-
long a disease in addition to those that
might cause it,” she says.
EBP workshop participants stressed
that metabolomic, proteomic, and genom-
ic methods offer new opportunities for bio-
marker development. DNA and protein
adducts in particular could provide windows
into the body’s long-term “memory” of pre-
vious exposures, they suggested. Metabolite
profiles, meanwhile, could offer shorter-term
measures of environmental response. Perera
explains, “The DNA and protein adducts in
peripheral blood—at least for polycyclic aro-
matic hydrocarbons in settings of constant
exposure—have lifetimes on the order of
several months. The metabolite profiles are
likely to be more short-lived.”
Bruce Hammock, a professor of ento-
mology and toxicology at the University of
California, Davis, says metabolomics—like
the other “omic” sciences—has benefited
from economies of scale that have dramati-
cally reduced analytical costs. He says the
growing capacity to measure dozens, even
hundreds, of metabolites simultaneously
opens doors for two types of research. 
The first involves an unbiased interroga-
tion of all measurable metabolites induced
by a particular environmental exposure.
This global approach could yield biomark-
ers linking the exposure to entirely new and
perhaps unexpected diseases. “Say we’re
studying air pollution and asthma,” Smith
says. “Recent evidence shows airborne par-
ticulates play an important role in heart dis-
ease, so if you focus just on asthma, then
you might miss that additional connection.” 
With the second type of research, sci-
entists could investigate specific metabolic
pathways linked to a specific ailment—for
instance, air pollution–induced inflamma-
tion and heart disease. This hypothesis-
driven method would allow scientists to
backtrack along the exposure response to
biomarkers that offer clues to underlying
physiology.
Another point to consider, Groopman
adds, is that mass spectrometry is 1,000-
fold more sensitive today than it was 15 to
20 years ago, which makes it possible to
detect ever-smaller concentrations of
chemicals in a given sample. Scientists who
previously might have detected a pollutant
in the blood of just a few subjects might
now find it at very low levels in many
more, he says. And by linking those pollu-
tant analyses with corresponding gene,
protein, and metabolite profiles in exposed
people, it might finally be possible to assess
the health effects of low-level chemical
mixtures, which has long been a holy grail
for environmental health scientists. 
Social Concerns and Regulatory
Implications
As it stands now, the coming era of per-
sonal exposure assessment is poised for
takeoff. Dialogue, collaboration, and the
promise of funding have brought a prelim-
inary vision into focus, and the next several
years will see increasingly refined tech-
nologies applied to the field. But exposure
assessment’s new direction also raises some
difficult questions. In the not-too-distant
future, thousands of people could be
enrolled in highly invasive studies, their
pollutant levels, diets, movements, and
physical activities all monitored in real
time with wireless sensors linked to grow-
ing databases. Kathy Hudson, who directs
the Genetics and Public Policy Center in
Washington, DC, says, “We’re talking
about peering into people’s private lives in
a very profound way, so the question is
whether they will accept that intrusion
into their personal space.”
Who would participate in these stud-
ies? “Certainly highly motivated people,”
Weis answers. “Parents who have kids with
asthma would be more likely to enroll.
We’re trying to address this issue now—we
know data collection devices would have
to be portable and easy to carry around.” 
Linda Sheldon, the acting director for
human exposure and atmospheric sciences
at the EPA, suggests researchers need to
reach out to prospective communities and
listen to their concerns. “You have to work
with community groups and help them
understand how this knowledge can bene-
fit them and society in general,” she says.
“And you really need to focus on people
who are interested in the environment and
its impacts on their health and the health
of their kids.” 
Beyond the recruitment challenges,
gene–environment research in general
raises questions about genetic privacy.
Could subjects be harmed by relinquishing
genetic information to the public? Hudson
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Making the connection. A major goal of exposure biology
is to identify specific biomarkers of exposure to agents such
as vehicular air pollution and environmental tobacco smoke,
then link them to mechanisms of disease.says there’s little evidence to suggest indi-
viduals are more concerned about disclos-
ing their genotypes than they are about
disclosing the dietary and lifestyle factors
already used in health research. But she con-
cedes the GEI and future larger-scale proj-
ects are breaking new ground in this area.
“For all these data to be used to expand
our knowledge of disease, they have to be
widely available,” Hudson says. “So, we
have to consider the kinds of access and
uses we want to prevent. On the one hand,
we want that [gene–environment] informa-
tion to be available, but on the other hand
we don’t want those who give of themselves
to research to put themselves at risk.” 
Hudson says researchers also need to
consider the consequences of their find-
ings. For instance, she asks, how and at
what point are correlations that link expo-
sure and environmental disease relayed
back to the public? Who pays for the
removal of confirmed risk factors and the
treatment of identified health conditions?
What obligations do researchers have to
communicate findings to their cohorts?
“You really have to think carefully about all
these outcomes,” Hudson says.
Over time, findings that emerge from
exposure assessment’s growing alliance
with genetics could produce social benefits
by improved regulation. Sheldon says that
whereas the EPA built its success on
addressing “the big, obvious pollution
problems,” it is now facing more subtle
issues such as understanding and managing
health risks from low-level pollutant mix-
tures to which most people are exposed. 
“We need more precise tools to under-
stand the problems we face now,” Hudson
says. “Once these chemicals pass into the
body, the effects may be different in differ-
ent people—we need to get a better handle
on the sequence of events that ultimately
leads to a health outcome.” 
Ultimately, this could help us improve
the safety factors we use in risk assessment
as well as truly understand the risks. “The
findings may not translate immediately,”
says Sheldon, “but as the science builds up
it will have an impact.” 
Moving Forward
As the EBP moves forward, a GEI Sub-
committee on Exposure Biology made up
of experts from throughout the NIH is
meeting on a biweekly basis in Bethesda to
discuss priorities and progress. According
to Weis, discussions emphasize fiscal year
2007 research initiatives in environmental
sensors and biomarker development,
which will address assessment needs for
environmental pollutants, diet, physical
activity, and even psychosocial stressors.
Meanwhile, a counterpart GEI Genetics
Subcommittee is addressing ongoing issues
related to the initiative’s genome associa-
tion studies. Both subcommittees are open
to all NIH staff.
Summing up, Perera suggests that
emerging advances in exposure assessment
will allow researchers to make better use of
population resources. 
“Everyone’s excited about moving on
to this next level,” she says. “Researchers
like us are eager to do more with our
cohorts, and to find new molecular links
between exposure and disease. This is all
really about identifying preventable envi-
ronmental exposures and their role in dis-
eases that are extremely prevalent in our
society.” 
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